CAS: 718612-51-2 - 1H-Pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-11-(ethyl-d<sub>5</sub>)-4,9-dihydroxy-, (4S)-
Formula:C22H15D5N2O5
InChI:InChI=1S/C22H20N2O5/c1-3-12-13-7-11(25)5-6-17(13)23-19-14(12)9-24-18(19)8-16-15(20(24)26)10-29-21(27)22(16,28)4-2/h5-8,25,28H,3-4,9-10H2,1-2H3/t22-/m0/s1/i1D3,3D2
InChI key:InChIKey=FJHBVJOVLFPMQE-BOQQFKKFSA-N
SMILES:O=C1OCC=2C(=O)N3C(=CC2C1(O)CC)C=4N=C5C=CC(O)=CC5=C(C4C3)CC
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Irinotecan EP Impurity E-d5 (Irinotecan USP Related Compound B-d5, (S)-7-Ethyl-10-Hydroxy Camptothecin-d5) REF: 4Z-I-1842CAS: 718612-51-2 | - - - | To inquire | Tue 07 Jan 25 |
Irinotecan EP Impurity E-d5 (Irinotecan USP Related Compound B-d5, (S)-7-Ethyl-10-Hydroxy Camptothecin-d5)
CAS:718612-51-2
Formula:
C22H15D5N2O5
Molecular weight:
397.44
Ref: 4Z-I-1842
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025